Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Myelodysplastic Syndromes"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Myelodysplastic+Syndromes%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Myelodysplastic+Syndromes%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Myelodysplastic+Syndromes%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (250)
1
Collection of Tissue Samples for Cancer Research : Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation : A Phase I/II Open Label, Dose Escalation Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) : Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)- a Cluster Randomized Controlled Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. : A Phase 1/1b Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of LP-118 in Subjects With Relapsed or Refractory Hematological Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation : A Randomized Phase II Study to Compare the Net Clinical Benefit of Cyclosporine and Sirolimus Combined With MMF or Post-Transplant Cyclophosphamide as GVHD Prophylaxis After HLA-Matched or HLA-Mismatched Unrelated G-CSF Mobilized Blood Cell Transplantation Using Nonmyeloablative or Reduced Intensity Conditioning for Patients With Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma : Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide : Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer : A Phase II Trial of Haploidentical Allogeneic Stem Cell Transplantation Utilizing Mobilized Peripheral Blood Stem Cells
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant : A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer : A Phase Ib Study to Evaluate Safety and Persistence of ex Vivo Expanded Universal Donor NK Cells in Combination With IL-2 and TGFbeta Receptor I Inhibitor Vactosertib in Patients With Locally Advanced/Metastatic Colorectal Cancer and Relapsed/Refractory Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Myelodysplastic Syndromes
Medienart
250
Aufsätze
250
E-Artikel
250
E-Ressourcen
Zeitschriftentitel
250
ClinicalTrials.gov
Thema
250
610
Myelodysplastic Syndromes
238
Multiple Myeloma
213
Study Type: Interventional
202
Leukemia
167
Lymphoma
149
Preleukemia
133
Recruitment Status: Completed
120
Neoplasms, Plasma Cell
117
Syndrome
113
Myeloproliferative Disorders
93
Leukemia, Myeloid
92
Precursor Cell Lymphoblastic Leukemia-Lymphoma
83
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Leukemia, Lymphocytic, Chronic, B-Cell
76
Neoplasms
75
Leukemia, Myeloid, Acute
74
Myelodysplastic-Myeloproliferative Diseases
70
Phase: Phase 2
65
Leukemia, Lymphoid
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
112
2020-
135
2010-2019
3
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
250
Englisch
Haven't found what you're looking for?
Wird geladen...